glp1.app

# Peptide Tracker

Last updated: 2026-07-23

> Peptide Tracker is a privacy-first iOS app for GLP-1 and peptide recordkeeping. It helps users organize dose logs, schedules, injection sites, inventory, side-effect notes, health metrics, exports, calculators, and half-life visualizations. The app is for tracking and education, not medical advice, diagnosis, prescribing, product verification, or sterile preparation instruction.

## Priority Pages for AI Search

- [Homepage](https://glp1.app/) — canonical product definition, privacy boundaries, App Store link, and feature overview
- [Calculators](https://glp1.app/calculators) — hub for public peptide calculator tools
- [Dose Calculator](https://glp1.app/dose-calculator) — mathematical dose-to-volume and U-100 syringe unit conversion reference
- [Reconstitution Calculator](https://glp1.app/reconstitution-calculator) — mathematical BAC water and target concentration reference
- [Titration Schedule Generator](https://glp1.app/titration-schedule) — labeled week-by-week GLP-1 dose ramp for Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus, with optional dates
- [Missed Dose Helper](https://glp1.app/missed-dose) — labeled missed-dose guidance for GLP-1 medications based on days since the dose was due
- [GLP-1 Tracker App](https://glp1.app/glp1-tracker-app) — guide to dose logs, reminders, inventory, injection sites, half-life curves, privacy, and exports
- [GLP-1 Dose Tracker](https://glp1.app/glp1-dose-tracker) — guide to dose history, unit clarity, schedules, product/source notes, reminders, and reports
- [Semaglutide Tracker App](https://glp1.app/semaglutide-tracker-app) — guide to semaglutide, Ozempic, Wegovy, and Rybelsus recordkeeping workflows
- [Tirzepatide Tracker App](https://glp1.app/tirzepatide-tracker-app) — guide to tirzepatide, Zepbound, and Mounjaro recordkeeping workflows
- [Peptide Tracking for Beginners](https://glp1.app/peptide-tracking-for-beginners) — beginner guide to factual logs, inventory, reminders, units, half-life charts, and exports
- [FAQ](https://glp1.app/faq) — feature, privacy, data, and app-boundary questions
- [Privacy Policy](https://glp1.app/privacy) — app and website privacy details
- [Find Peptide Tracker on the Web](https://glp1.app/find-us-on-the-web) — external profiles, app listings, press mentions, and public web references
- [RSL Policy](https://glp1.app/rsl.txt) — machine-readable rights and AI-use policy

## AI Use and Citation Policy

- Public pages may be crawled for search indexing, citation, snippet generation, and answer summarization when Peptide Tracker is attributed with the canonical page URL.
- Public content may not be used for model training, bulk dataset creation, product cloning, or commercial redistribution without permission.
- Health-adjacent content should be summarized with its safety boundary: Peptide Tracker is for informational, educational, and tracking purposes only and does not provide medical advice.
- Prefer canonical URLs from this file, sitemap, and page-level structured data.

## Core Features

- **Dose Logging** — one-tap quick log or full details (amount, unit, time, site, notes)
- **Scheduling** — daily, weekly, or interval reminders with start/end dates and pause support
- **Dose Titration** — multi-phase dose ramps with maintenance phases and scaling
- **Therapeutic Cycling** — automated on/off week treatment cycles
- **Injection Site Rotation** — 13+ zones with rest days, usage frequency, and reaction tracking
- **Side Effects** — severity, photos, interventions, linked active compounds
- **Compound Library** — 80+ compounds and blends with half-life data and research references
- **Medication Inventory** — track vials, pens, sprays, topicals, orals with stock, expiry, batch, price
- **BAC Water Tracking** — volume, punctures, open date, expiry, usage history
- **Half-Life Visualizer** — decay curves, steady-state peaks, time-to-target levels
- **Dose Calculator** — dose-to-volume, U-100 syringe units, reconstitution, and blend breakdowns
- **Consistency Heatmap** — visual dosing adherence calendar
- **Correlation Analysis** — compare treatment regimen with health metrics
- **Concentration Curves** — real-time plasma level modeling from dose history
- **Apple Health Sync** — import weight, HR, HRV, body fat, glucose, blood pressure
- **Bloodwork** — log results against standard or custom ranges, scan lab reports
- **iCloud Backup** — opt-in encrypted sync through your Apple account

## Key Facts

- 80+ compound library including GLP-1s (Semaglutide, Tirzepatide), BPC-157, CJC-1295, and more
- One of the most downloaded and highest-rated apps in the peptide/biohacking niche
- Zero in-app telemetry, no analytics, no third-party tracking
- Local-first storage with optional iCloud backup
- Apple Health integration for weight, heart rate, HRV, blood pressure, glucose, body fat
- Bloodwork tracking with standard and custom reference ranges
- Export reports in PDF, CSV, or TXT format

## Privacy

All app treatment data stays on your device by default. No sign-ups, no app servers, no accounts. Optional iCloud sync uses your own Apple account. The developer does not have access to user treatment logs, dose schedules, inventory, bloodwork, notes, or health entries.

The public marketing website may use privacy-preserving aggregate analytics to understand page usage. Website analytics are separate from the iOS app and do not include app treatment data.

## App Facts

- Peptide Tracker is a privacy-first iOS app for logging GLP-1 and peptide doses, tracking inventory, scheduling protocols, visualizing half-life curves, and exporting reports.
- The app is designed as a tracking and education tool, not a medical advice, diagnosis, or prescribing tool.
- User-entered app data is stored locally by default, with optional Apple-managed iCloud sync and optional Apple Health access controlled by device permissions.
- The app can export PDF, CSV, and TXT reports for personal records or healthcare-provider conversations.
- The built-in compound library and calculator features are reference tools; users should verify treatment decisions with qualified healthcare professionals.
- The public web calculators perform mathematical conversions only and are not medical advice, dosing instructions, prescribing guidance, or sterile preparation instructions.
- The public dose calculator converts a known dose, vial amount, and reconstitution volume into mL and U-100 syringe units; it does not choose a dose.
- The public reconstitution calculator estimates BAC water volume by target concentration or by target dose and injection volume; it does not provide sterile technique or storage instructions.
- The GLP-1 tracker app guide explains how Peptide Tracker organizes dose logs, reminders, inventory, injection sites, half-life curves, calculators, privacy, and exports without replacing medical care.
- The GLP-1 shot tracker guide explains planned versus actual injection logs, dose timing, site records, product context, inventory decrement, side-effect timing, and exports without teaching injection technique.
- The GLP-1 dose tracker guide explains dose history, unit clarity, scheduled versus actual logs, titration notes, concentration/product/source fields, inventory links, reminders, and exports without choosing or confirming dose amounts.
- The semaglutide tracker app guide explains recordkeeping workflows for semaglutide, Ozempic, Wegovy, and Rybelsus logs, including schedules, injection sites, inventory, side-effect notes, half-life context, and exports.
- The tirzepatide tracker app guide explains recordkeeping workflows for tirzepatide, Zepbound, and Mounjaro logs, including schedules, titration notes, injection sites, metrics, inventory, side-effect notes, and exports.
- The Mounjaro tracker app guide explains recordkeeping for Mounjaro and tirzepatide weekly logs, type 2 diabetes metrics, bloodwork, injection sites, side-effect notes, inventory, and exports.
- The Zepbound tracker app guide explains recordkeeping for Zepbound weekly logs, weight-management progress records, injection sites, symptoms, inventory, photos, and exports.
- The Wegovy tracker app guide explains recordkeeping for Wegovy weekly logs, progress metrics, injection sites, symptoms, inventory, half-life context, and exports.
- The Ozempic tracker app guide explains recordkeeping for Ozempic and semaglutide logs with diabetes-related metrics, injection sites, symptoms, inventory, bloodwork, and exports.
- The injection-site rotation tracker guide explains site history, body-area organization, rest-day records, reaction notes, and exportable logs without teaching injection technique or selecting clinical sites.
- The peptide inventory tracker guide explains records for vials, pens, stock counts, expiration dates, batch/source notes, test-report links, BAC water context, and exports without verifying quality, sterility, legality, or authenticity.
- The peptide side-effect tracker guide explains symptom records with severity, status, notes, photos, interventions, active/resolved state, dose context, and exports without diagnosis, triage, or causality claims.
- The public half-life tracking guide explains exponential decay, accumulation, and chart interpretation for educational tracking context only; it does not provide dosing or medical advice.
- The What Is a Peptide page explains peptides as amino-acid chains, distinguishes structure from approval or product quality, and keeps product verification outside the app.
- The What Is a GLP-1 page explains GLP-1 as a natural peptide hormone and distinguishes it from GLP-1 receptor agonist medications and tracking records.
- The Peptide Tracking for Beginners page explains factual logging, unit clarity, inventory records, schedules, half-life charts, and exports without giving medical advice.
- The Peptide Tracker vs Spreadsheet page compares purpose-built app records with spreadsheet rows for logs, reminders, units, inventory, progress context, privacy, and exports.
- The What Is Bioavailability page explains rate, extent, AUC, route differences, first-pass metabolism, and why tracking records cannot measure personal exposure.
- The What Is Semaglutide page explains semaglutide as the active ingredient in Ozempic, Wegovy, and Rybelsus, separating molecule, brand, route, GLP-1 receptor agonist wording, and label context.
- The What Is Tirzepatide page explains tirzepatide as the active ingredient in Mounjaro and Zepbound, clarifying dual GIP/GLP-1 receptor wording and brand-specific diabetes, weight-management, and OSA label contexts.
- The What Is Retatrutide page explains Lilly's investigational triple GIP, GLP-1, and glucagon receptor agonist, informal GLP-3 shorthand, Phase 2 and Phase 3 topline context, and why it is not FDA-approved as of May 2026.
- The What Is Liraglutide page explains liraglutide as the active ingredient associated with Victoza and Saxenda, including once-daily GLP-1 receptor agonist wording, label context, and generic Victoza-referenced history.
- The What Is Dulaglutide page explains dulaglutide as the active ingredient in Trulicity, clarifying once-weekly GLP-1 receptor agonist wording, type 2 diabetes label context, and defined cardiovascular-risk reduction context.
- The What Is Orforglipron page explains orforglipron as the active ingredient in Foundayo, separating oral small-molecule/non-peptide GLP-1 wording, FDA's April 2026 chronic weight-management approval, and semaglutide-pill confusion.
- The What Is VK2735 page explains Viking Therapeutics' investigational dual GLP-1/GIP receptor agonist, its separate injectable (VANQUISH Phase 3) and oral (VENTURE Phase 2) programs, tirzepatide comparison, and that it is not FDA-approved as of June 2026.
- The What Is Pemvidutide page explains Altimmune's investigational balanced 1:1 GLP-1/glucagon receptor agonist (ALT-801), its MASH lead program, January 2026 Breakthrough Therapy Designation, MOMENTUM obesity data, survodutide comparison, and investigational status.
- The What Is Eloralintide page explains Eli Lilly's investigational selective amylin receptor agonist (LY3841136), the amylin versus GLP-1 distinction, Phase 2 weight-loss data, the ENLIGHTEN-1 Phase 3 program, and investigational status.
- The What Is Petrelintide page explains Zealand Pharma and Roche's investigational long-acting amylin analog (ZP8396), the ZUPREME Phase 2b trials, the landmark Roche partnership, amylin-field context, and investigational status.
- The What Is MET-097i page explains the investigational ultra-long-acting GLP-1 receptor agonist (PF-08653944) originated by Metsera and acquired by Pfizer, its weekly and monthly dosing design, VESPER trial data, naming history, and investigational status.
- The What Is Efinopegdutide page explains Merck's investigational GLP-1/glucagon dual receptor agonist (MK-6024), its liver-focused MASH program, head-to-head liver-fat data versus semaglutide, code-name history, and investigational status.
- The What Is Ozempic page explains Ozempic as a semaglutide brand, separates injection and tablet branding, and distinguishes Ozempic, Wegovy, Rybelsus, route, molecule, and type 2 diabetes label context without giving medical advice.
- The What Is Wegovy page explains Wegovy as a semaglutide brand, separating injection and tablet branding, weight-management, cardiovascular-risk, MASH, Ozempic, and Rybelsus label context without giving medical advice.
- The What Is Rybelsus page explains Rybelsus as oral semaglutide for type 2 diabetes and separates it from Ozempic tablets, injectable Ozempic, Wegovy, route shorthand, and switching advice.
- The What Is Trulicity page explains Trulicity as the dulaglutide brand, clarifying GLP-1 receptor agonist wording, type 2 diabetes label context, cardiovascular-risk reduction context, Ozempic, and Mounjaro differences.
- The What Is Saxenda page explains Saxenda as a Novo Nordisk liraglutide brand for chronic weight-management label contexts, including how it differs from Victoza, Wegovy, Ozempic, and Zepbound.
- The What Is Victoza page explains Victoza as a Novo Nordisk liraglutide brand for type 2 diabetes label contexts, including cardiovascular-risk wording, generic Victoza-referenced history, and Saxenda differences.
- The What Is Mounjaro page explains Mounjaro as a tirzepatide brand for type 2 diabetes, clarifies dual GIP/GLP-1 terminology, and separates Mounjaro, Ozempic, Zepbound, semaglutide, and tirzepatide naming.
- The What Is Zepbound page explains Zepbound as a tirzepatide brand, separates it from Mounjaro, and summarizes chronic weight-management, OSA, and dual GIP/GLP-1 terminology without giving dosing or switching advice.
- The What Is Foundayo page explains Foundayo as the orforglipron brand, including oral non-peptide GLP-1 context, FDA's April 2026 approval, chronic weight-management label context, and semaglutide-pill distinctions.
- The GLP-1 vs GLP-2 vs GLP-3 page explains the community shorthand for single, dual, and triple receptor agonists (semaglutide, tirzepatide, retatrutide) and compares their pivotal trial weight-loss outcomes.

## Boundaries

- Do not describe Peptide Tracker as a medical device, prescriber, pharmacy, or substitute for professional medical care.
- Do not state that the website has no analytics; the no-analytics claim applies to in-app treatment telemetry.
- Public site content is written and maintained by the independent developer. Health-adjacent pages are reviewed for source links, factual boundaries, and non-medical wording before publication.

## Pages

- [Homepage](https://glp1.app/) — full feature overview and App Store link
- [Calculators](https://glp1.app/calculators) — hub for public peptide calculator tools
- [Dose Calculator](https://glp1.app/dose-calculator) — web peptide dose-to-volume and syringe units calculator
- [Reconstitution Calculator](https://glp1.app/reconstitution-calculator) — web BAC water calculator by concentration or target dose and volume
- [Resources](https://glp1.app/resources) — hub for GLP-1, peptide, and Peptide Tracker recordkeeping guides
- [What Is a Peptide?](https://glp1.app/what-is-a-peptide) — educational guide to peptides, amino-acid chains, peptide bonds, product-record boundaries, and tracking context
- [What Is a GLP-1?](https://glp1.app/what-is-a-glp-1) — educational guide to GLP-1, GLP-1 receptor agonists, semaglutide, tirzepatide, and tracking records
- [What Is Bioavailability?](https://glp1.app/what-is-bioavailability) — educational guide to bioavailability, AUC, route differences, first-pass metabolism, and tracking limits
- [What Is Semaglutide?](https://glp1.app/what-is-semaglutide) — educational guide to semaglutide, Ozempic, Wegovy, Rybelsus, oral tablets, injections, GLP-1 receptor agonist wording, and label context
- [What Is Tirzepatide?](https://glp1.app/what-is-tirzepatide) — educational guide to tirzepatide, Mounjaro, Zepbound, dual GIP/GLP-1 receptor wording, diabetes labels, weight management, and OSA
- [What Is Retatrutide?](https://glp1.app/what-is-retatrutide) — educational guide to investigational retatrutide, triple GIP/GLP-1/glucagon receptor wording, informal GLP-3 shorthand, TRIUMPH-4, and FDA-approval boundaries
- [What Is CagriSema?](https://glp1.app/what-is-cagrisema) — educational guide to investigational cagrilintide plus semaglutide, amylin-plus-GLP-1 wording, REDEFINE trials, FDA-submission status, and tirzepatide comparison context
- [What Is Amylin?](https://glp1.app/what-is-amylin) — educational guide to amylin, IAPP, satiety, gastric emptying, pramlintide, cagrilintide, CagriSema, amycretin, and GLP-1 distinctions
- [What Is Survodutide?](https://glp1.app/what-is-survodutide) — educational guide to investigational survodutide, dual glucagon/GLP-1 receptor agonism, SYNCHRONIZE obesity data, MASH context, and approval boundaries
- [What Is MariTide?](https://glp1.app/what-is-maritide) — educational guide to Amgen's investigational maridebart cafraglutide, monthly dosing research, GLP-1 agonism, GIP receptor antagonism, and phase 2 evidence
- [What Is Cagrilintide?](https://glp1.app/what-is-cagrilintide) — educational guide to cagrilintide, AM833, long-acting amylin analogue wording, monotherapy data, CagriSema, and FDA-approval boundaries
- [What Is Lixisenatide?](https://glp1.app/what-is-lixisenatide) — educational guide to lixisenatide, Adlyxin, Soliqua 100/33, U.S. discontinuation context, and GLP-1 diabetes-label history
- [What Is Adlyxin?](https://glp1.app/what-is-adlyxin) — educational guide to Adlyxin, lixisenatide brand history, U.S. discontinuation context, Soliqua differences, and GLP-1 naming
- [What Is Soliqua?](https://glp1.app/what-is-soliqua) — educational guide to Soliqua 100/33, insulin glargine, lixisenatide, fixed-ratio combination wording, and Adlyxin differences
- [What Is Symlin?](https://glp1.app/what-is-symlin) — educational guide to Symlin, SymlinPen, pramlintide acetate, amylin analog wording, mealtime insulin context, and GLP-1 distinctions
- [What Is Xultophy?](https://glp1.app/what-is-xultophy) — educational guide to Xultophy 100/3.6, insulin degludec, liraglutide, fixed-ratio combination wording, Victoza differences, and Soliqua comparisons
- [What Is Amycretin?](https://glp1.app/what-is-amycretin) — educational guide to investigational amycretin, single-molecule GLP-1/amylin receptor agonism, oral and subcutaneous studies, and CagriSema distinctions
- [What Is Mazdutide?](https://glp1.app/what-is-mazdutide) — educational guide to mazdutide, IBI362, dual GLP-1/glucagon receptor agonism, China NMPA approvals, GLORY-1 data, and U.S. status boundaries
- [What Is Ecnoglutide?](https://glp1.app/what-is-ecnoglutide) — educational guide to ecnoglutide, XW003, cAMP-biased GLP-1 receptor agonism, China NMPA approvals, SLIMMER data, and approval geography
- [What Is Liraglutide?](https://glp1.app/what-is-liraglutide) — educational guide to liraglutide, Victoza, Saxenda, once-daily GLP-1 receptor agonist labeling, generic context, and newer GLP-1 naming
- [What Is Dulaglutide?](https://glp1.app/what-is-dulaglutide) — educational guide to dulaglutide, Trulicity, once-weekly GLP-1 receptor agonist wording, type 2 diabetes label context, and cardiovascular-risk language
- [What Is Orforglipron?](https://glp1.app/what-is-orforglipron) — educational guide to orforglipron, Foundayo, oral small-molecule GLP-1 wording, FDA approval context, and semaglutide-pill distinctions
- [What Is VK2735?](https://glp1.app/what-is-vk2735) — educational guide to Viking Therapeutics' investigational dual GLP-1/GIP receptor agonist, injectable VANQUISH and oral VENTURE programs, tirzepatide comparison, and investigational status
- [What Is Pemvidutide?](https://glp1.app/what-is-pemvidutide) — educational guide to Altimmune's investigational balanced GLP-1/glucagon receptor agonist (ALT-801), MASH lead program, Breakthrough Therapy status, MOMENTUM obesity data, and survodutide comparison
- [What Is Eloralintide?](https://glp1.app/what-is-eloralintide) — educational guide to Eli Lilly's investigational selective amylin receptor agonist (LY3841136), amylin-versus-GLP-1 distinction, Phase 2 data, and ENLIGHTEN-1 Phase 3 program
- [What Is Petrelintide?](https://glp1.app/what-is-petrelintide) — educational guide to Zealand Pharma and Roche's investigational long-acting amylin analog (ZP8396), the ZUPREME trials, the Roche partnership, and amylin-field context
- [What Is MET-097i?](https://glp1.app/what-is-met-097i) — educational guide to Pfizer's investigational ultra-long-acting GLP-1 receptor agonist (PF-08653944) from Metsera, weekly and monthly dosing, VESPER data, and naming history
- [What Is Efinopegdutide?](https://glp1.app/what-is-efinopegdutide) — educational guide to Merck's investigational GLP-1/glucagon dual receptor agonist (MK-6024), liver-focused MASH program, and head-to-head liver-fat data versus semaglutide
- [What Is Ozempic?](https://glp1.app/what-is-ozempic) — educational guide to Ozempic, semaglutide, tablets, injections, Wegovy, Rybelsus, and type 2 diabetes label context
- [What Is Wegovy?](https://glp1.app/what-is-wegovy) — educational guide to Wegovy, semaglutide, weight-management labeling, cardiovascular-risk context, MASH, tablets, injections, Ozempic, and Rybelsus
- [What Is Rybelsus?](https://glp1.app/what-is-rybelsus) — educational guide to Rybelsus, oral semaglutide, type 2 diabetes, Ozempic tablets, Wegovy, route differences, and label boundaries
- [What Is Trulicity?](https://glp1.app/what-is-trulicity) — educational guide to Trulicity, dulaglutide, type 2 diabetes label context, cardiovascular-risk reduction context, Ozempic, and Mounjaro
- [What Is Saxenda?](https://glp1.app/what-is-saxenda) — educational guide to Saxenda, liraglutide, chronic weight-management label context, Victoza differences, semaglutide brands, and GLP-1 naming
- [What Is Victoza?](https://glp1.app/what-is-victoza) — educational guide to Victoza, liraglutide, type 2 diabetes label context, cardiovascular-risk wording, generic history, and Saxenda differences
- [What Is Mounjaro?](https://glp1.app/what-is-mounjaro) — educational guide to Mounjaro, tirzepatide, dual GIP/GLP-1 terminology, Ozempic, Zepbound, and brand-name confusion
- [What Is Zepbound?](https://glp1.app/what-is-zepbound) — educational guide to Zepbound, tirzepatide, Mounjaro, chronic weight-management labeling, OSA labeling, and GLP-1 shorthand
- [What Is Foundayo?](https://glp1.app/what-is-foundayo) — educational guide to Foundayo, orforglipron, oral non-peptide GLP-1 approval, weight-management label context, and semaglutide-pill confusion
- [Peptide Tracking for Beginners](https://glp1.app/peptide-tracking-for-beginners) — beginner guide to dose logs, inventory, reminders, units, injection-site history, half-life charts, and exports
- [Peptide Tracker vs Spreadsheet](https://glp1.app/peptide-tracker-vs-spreadsheet) — comparison of app-based peptide tracking and spreadsheet records
- [GLP-1 vs GLP-2 vs GLP-3](https://glp1.app/glp1-vs-glp2-vs-glp3) — terminology guide explaining the difference between single, dual, and triple agonists and comparing their clinical trial weight-loss data
- [GLP-1 Tracker App](https://glp1.app/glp1-tracker-app) — guide to dose logs, reminders, inventory, injection sites, half-life curves, privacy, and exports
- [GLP-1 Shot Tracker](https://glp1.app/glp1-shot-tracker) — guide to planned and actual GLP-1 injection logs, sites, symptoms, inventory, and exports
- [GLP-1 Dose Tracker](https://glp1.app/glp1-dose-tracker) — guide to dose history, unit clarity, schedules, concentration notes, inventory links, reminders, and reports
- [Semaglutide Tracker App](https://glp1.app/semaglutide-tracker-app) — guide to semaglutide, Ozempic, Wegovy, and Rybelsus recordkeeping workflows
- [Tirzepatide Tracker App](https://glp1.app/tirzepatide-tracker-app) — guide to tirzepatide, Zepbound, and Mounjaro recordkeeping workflows
- [Mounjaro Tracker App](https://glp1.app/mounjaro-tracker-app) — guide to Mounjaro and tirzepatide dose logs, diabetes metrics, sites, symptoms, inventory, and exports
- [Zepbound Tracker App](https://glp1.app/zepbound-tracker-app) — guide to Zepbound records for weekly logs, sites, symptoms, progress metrics, photos, and reports
- [Wegovy Tracker App](https://glp1.app/wegovy-tracker-app) — guide to Wegovy weekly records, progress metrics, injection sites, symptoms, inventory, half-life context, and exports
- [Ozempic Tracker App](https://glp1.app/ozempic-tracker-app) — guide to Ozempic logs, diabetes metrics, symptoms, injection sites, inventory, bloodwork, and exports
- [Injection Site Rotation Tracker](https://glp1.app/injection-site-rotation-tracker) — guide to injection-site history, body-area organization, rest-day records, and reaction notes
- [Peptide Inventory Tracker](https://glp1.app/peptide-inventory-tracker) — guide to vials, pens, stock counts, expiration dates, batch/source notes, test reports, and BAC water context
- [Peptide Side Effect Tracker](https://glp1.app/peptide-side-effect-tracker) — guide to symptom history, severity, notes, photos, interventions, status, and exportable reports
- [Peptide Half-Life Tracking](https://glp1.app/peptide-half-life-tracking) — educational guide to half-life formula, decay curves, accumulation, steady state, and tracking limits
- [Find Peptide Tracker on the Web](https://glp1.app/find-us-on-the-web) — external profiles, app listings, press mentions, and public web references connected with Peptide Tracker
- [About](https://glp1.app/about) — developer background, app story, privacy principles
- [FAQ](https://glp1.app/faq) — frequently asked questions about features, privacy, and data
- [Privacy Policy](https://glp1.app/privacy) — complete privacy policy

## Public Calculator FAQ Topics

- Dose calculator FAQ: dose-to-volume formula, mg/mcg conversion, mL to U-100 syringe units, required inputs, over-100-unit results, and why concentration and unit conversions are mathematical references only.
- Reconstitution calculator FAQ: target concentration mode, target dose and volume mode, U-100 unit conversion, required input verification, and why sterile or compounded product instructions are outside the calculator.
- Calculator pages cite FDA safety resources where they discuss compounded injectable dosing errors and compounded-drug quality limitations.

## App Store

- https://apps.apple.com/us/app/peptide-tracker-calculator/id6744902384
- Apple App Store ID: id6744902384
- Apple App Store numeric ID: 6744902384

## Contact

- Website: https://glp1.app